Cargando…
Severe cutaneous adverse reactions associated with systemic ivermectin: A pharmacovigilance analysis
Despite poor evidence, the antiparasitic ivermectin has been advocated as a potential COVID‐19 therapy. This has led to a rise in calls to poison‐control centers by people self‐medicating with ivermectin, which is sold over the counter for veterinary uses. We aimed to investigate the association bet...
Autores principales: | Bomze, David, Sprecher, Eli, Geller, Shamir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111106/ https://www.ncbi.nlm.nih.gov/pubmed/35475524 http://dx.doi.org/10.1111/1346-8138.16398 |
Ejemplares similares
-
Preventing adverse cutaneous reactions from amplified hygiene practices during the COVID-19 pandemic: how dermatologists can help through anticipatory guidance
por: MacGibeny, Margaret A., et al.
Publicado: (2020) -
Uncommon Adverse Drug Reaction to a Commonly Used Antihypertensive
por: Soni, Rajesh, et al.
Publicado: (2020) -
Enfortumab Vedotin-Induced Toxic Epidermal Necrolysis: A Rare Fatal Adverse Reaction
por: Bansal, Aditi, et al.
Publicado: (2022) -
Cutaneous angiosarcoma of scalp
por: Kumar, Sawan, et al.
Publicado: (2017) -
Increase in Outpatient Ivermectin Dispensing in the US During the COVID-19 Pandemic: A Cross-Sectional Analysis
por: Lind, Jennifer N., et al.
Publicado: (2021)